Search Within

Larry Norton

  1. "Population Sciences Research Program"
Formats
  1. Journal Article (95)
  2. Meeting Abstract (87)
  3. Editorial (2)
Groups
  1. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (184)
  2. Breast Medicine Service (184)
  3. Department of Medicine (184)
  4. Population Sciences Research Program (184)
  5. Solid Tumor Oncology Division (184)
  6. Survivorship Research (172)

More Groups

People
  1. Clifford Hudis (96)
  2. Mark Robson (89)
  3. Chau Dang (55)
  4. Katherine Panageas (47)
  5. Kenneth Offit (45)
  6. Maura Dickler (34)

More People

Years
  1. 2024 (8)
  2. 2023 (6)
  3. 2022 (3)
  4. 2021 (3)
  5. 2020 (12)
  6. 2019 (13)

More Years

Publications
  1. Journal of Clinical Oncology (49)
  2. Breast Cancer Research and Treatment (22)
  3. Cancer Research (17)
  4. Clinical Cancer Research (12)
  5. Laboratory Investigation (7)
  6. American Journal of Human Genetics (6)

More Publications

Publishers
  1. American Society of Clinical Oncology (50)
  2. American Association for Cancer Research (34)
  3. Springer (23)
  4. Nature Publishing Group (19)
  5. Oxford University Press (10)
  6. Cell Press (8)

More Publishers

Results (184)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase II study of gemcitabine (G), trastuzumab (H), and pertuzumab (P) for HER2-positive metastatic breast cancer (MBC) after prior pertuzumab-based therapy
    Meeting Abstract

    Iyengar, N. M.; Smyth, L. M.; Lake, D.; Gucalp, A.; Singh, J. C.; Traina, T. A.; DeFusco, P. A.; Dickler, M. N.; Fornier, M. N.; Goldfarb, S. B.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Diverse BRCA1 and BRCA2 reversion mutations in circulating cell-free DNA of therapy-resistant breast or ovarian cancer
    Journal Article

    Weigelt, B.; Comino-Méndez, I.; de Bruijn, I.; Tian, L.; Meisel, J. L.; Garcia-Murillas, I.; Fribbens, C.; Cutts, R.; Martelotto, L. G.; Ng, C. K. Y.; more...
    Clinical Cancer Research (2017)

    Fulltext@MSK | Save
  • Phase II study of gemcitabine, trastuzumab, and pertuzumab for HER2-positive metastatic breast cancer after prior pertuzumab-based therapy
    Meeting Abstract

    Iyengar, N. M.; Smyth, L. M.; Lake, D.; Gucalp, A.; Singh, J. C.; Traina, T. A.; Defusco, P.; Dickler, M. N.; Fornier, M. N.; Goldfarb, S. B.; more...
    Annals of Oncology (2017)

    Fulltext@MSK | Save
  • Pan-cancer analysis of bi-allelic alterations in homologous recombination DNA repair genes
    Journal Article

    Riaz, N.; Blecua, P.; Lim, R. S.; Shen, R.; Higginson, D. S.; Weinhold, N.; Norton, L.; Weigelt, B.; Powell, S. N.; Reis-Filho, J. S.
    Nature Communications (2017)

    Fulltext@MSK | Save
  • Genetic heterogeneity in therapy-naïve synchronous primary breast cancers and their metastases
    Journal Article

    Ng, C. K. Y.; Bidard, F. C.; Piscuoglio, S.; Geyer, F. C.; Lim, R. S.; de Bruijn, I.; Shen, R.; Pareja, F.; Berman, S. H.; Wang, L.; more...
    Clinical Cancer Research (2017)

    Fulltext@MSK | Save
  • American Society of Clinical Oncology position statement: Strategies for reducing cancer health disparities among sexual and gender minority populations
    Journal Article

    Griggs, J.; Maingi, S.; Blinder, V.; Denduluri, N.; Khorana, A. A.; Norton, L.; Francisco, M.; Wollins, D. S.; Rowland, J. H.
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Phase II study of gemcitabine, trastuzumab, and pertuzumab for HER2-Positive metastatic breast cancer after prior pertuzumab-based therapy
    Meeting Abstract

    Iyengar, N. M.; Smyth, L.; Lake, D.; Gucalp, A.; Singh, J. C.; Traina, T. A.; DeFusco, P.; Dickler, M. N.; Fornier, M. N.; Goldfarb, S.; more...
    Cancer Research (2017)

    Fulltext@MSK | Save
  • Pathologic complete response with neoadjuvant doxorubicin and cyclophosphamide followed by paclitaxel with trastuzumab and pertuzumab in patients with HER2-positive early stage breast cancer: A single center experience
    Journal Article

    Singh, J. C.; Mamtani, A.; Barrio, A.; Morrow, M.; Sugarman, S.; Jones, L. W.; Yu, A. F.; Argolo, D.; Smyth, L. M.; Modi, S.; more...
    The Oncologist (2017)

    Fulltext@MSK | Save
  • Phase II study of gemcitabine, trastuzumab, and pertuzumab for HER2-positive metastatic breast cancer after prior pertuzumab-based therapy
    Meeting Abstract

    Iyengar, N. M.; Smyth, L.; Lake, D.; Gucalp, A.; Singh, J.; Traina, T. A.; Defusco, P.; Dickler, M. N.; Fornier, M.; Goldfarb, S.; more...
    Annals of Oncology (2016)

    Fulltext@MSK | Save
  • Activity of HP-based therapies as third and later lines for the treatment of HER2-positive metastatic breast cancer: A retrospective study from a single institution
    Meeting Abstract

    Argolo, D.; Friedman, M.; Smyth, L.; Iyengar, N.; Singh, J.; Patil, S.; Norton, L.; Baselga, J.; Hudis, C.; Dang, C.
    Cancer Research (2016)

    Fulltext@MSK | Save